Q4 2021 Dynavax Technologies Corp Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies Fourth Quarter and Full Year 2021 Financial Results Call. As a reminder, this conference call is being recorded. (Operator Instructions)
I would now like to turn the call over to Nicole Arndt, Senior Manager, Investor Relations. You may begin.
Thank you. Good afternoon, and welcome to the Dynavax Fourth Quarter and Full Year 2021 Financial Results and Corporate Update Conference Call. In addition to our press release issued today, a supplementary slide presentation that accompanies today's call is available in the Events section of our website.
Before we begin, I advise you that we will be making forward-looking statements today, including, but not limited to, statements regarding potential market sizes, impact of ACIP recommendation, financial guidance and trends and potential future uses of CpG 1018 adjuvant.
These statements involve risks and uncertainties that could cause actual results to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |